focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 23.00
Ask: 25.00
Change: 0.75 (3.23%)
Spread: 2.00 (8.696%)
Open: 24.25
High: 24.00
Low: 22.75
Prev. Close: 23.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Angle hails study find; Eqtec buys plant in France

Wed, 20th Jul 2022 20:50

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

UK Oil & Gas PLC - exploration and production company focused on UK and Turkey - Says it will need to seek further finance before the middle of the fourth quarter to fund oil exploration in Turkey. The UK energy company says the operator of the Resan licence intends to shoot a new, unbudgeted seismic programme before continuing with the Basur appraisal drilling program. This, combined with a longer than expected seismic acquisition period, has required additional working capital and deferred the start of cash flows from a successful Basur well, UKOG explains. "Given the promising positive outlook derived from the company's Basur Phase 1 seismic programme, plus the confirmation from the oil seep that the area has an active light oil petroleum system, the company's focus for the forthcoming 6-9 months will be firmly upon the delivery of Phase 2 seismic and a new Basur appraisal well, now anticipated to be able to add near-term oil production to the company in H1 2023," it says.

----------

Chariot Ltd - Devon, England-based transitional energy firm focused on Africa - Sees material increase in its gas resources offshore Morocco so it can fast track its field development plans for the Anchois gas project. Anchois sees an 81% rise in high confidence 1C contingent resources to 365 billion cubic feet from 201 billion and a 76% rise in 2C contingent resources to 637 billion cubic feet, whilst prospective resources covering three undrilled targets at Anchois have been estimated at some 754 billion cubic feet. The total remaining recoverable resource at Anchois now stands at 1.4 trillion cubic feet.

----------

San Leon Energy PLC - Dublin-based oil & gas exploration company - Signs new USD16.0 million 4-year loan to ELI Malta with 14% coupon. In addition, San Leon subscribes for further 10% of ELI's diluted share capital.

----------

Angle PLC - Surrey, England-based medical diagnostics company - Notes results of a University of Athens study undertaken in early-stage non-small cell lung cancer. Study demonstrates the benefit of analysing epigenetic alterations in circulating tumour cells to assess patient prognosis. The company’s Parsortix technology was used to isolate circulating tumour cells that provide the tell-tale signs of the disease. "We are pleased to report on the use of the Parsortix system for the isolation of CTCs in early-stage NSCLC, showing potential to enable genetic analysis that provides informative prognostic information. This showcases the potential of liquid biopsy, using the Parsortix system, as a promising tool for the assessment of early-stage disease, which is a key priority for healthcare systems world-wide," says Chief Executive Officer Andrew Newland.

----------

Eqtec PLC - Cork, Ireland-based gasification company focused on turning waste into sustainable energy - Says French subsidiary has acquired and intends to upgrade and recommission a 6.5 megawatt electric waste-to-energy gasification plant in Villers-sous-Montrond, France. The plant is expected to generate a revenue of more than EUR10 million a year and construction work is expected to start in the first quarter of 2023. Eqtec said the plant, which has already received an investment of EUR35 million, will be acquired at nominal value, as the recommissioning will require a further investment of EUR30 million.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
4 Mar 2021 11:42

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Read more
18 Feb 2021 10:24

Angle Shares Jump On Recent Parsortix System Research Results

Angle Shares Jump On Recent Parsortix System Research Results

Read more
8 Feb 2021 17:09

IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix

IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix

Read more
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
20 Jan 2021 12:22

Angle Reports Parsortix System Can Isolate Circulating Tumour Cells

Angle Reports Parsortix System Can Isolate Circulating Tumour Cells

Read more
20 Jan 2021 10:40

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

Read more
3 Nov 2020 15:53

DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares

DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares

Read more
29 Oct 2020 14:46

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

Read more
27 Oct 2020 19:06

UPDATE: Angle Successfully Raises GBP20 Million In Placing

UPDATE: Angle Successfully Raises GBP20 Million In Placing

Read more
27 Oct 2020 12:37

IN BRIEF: Angle To Raise GBP20 Million To Fund Operations

IN BRIEF: Angle To Raise GBP20 Million To Fund Operations

Read more
22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Oct 2020 14:18

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

Read more
20 Oct 2020 08:58

FDA accepts Angle's review submission for Parsortix PC1

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.

Read more
28 Sep 2020 19:33

IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix

IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix

Read more
20 Aug 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.